Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/1999
03/25/1999CA2303178A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
03/25/1999CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999CA2301887A1 Method for treating proliferative diseases by therapy
03/24/1999EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them
03/24/1999EP0903348A1 Epothilone derivatives, preparation and utilization
03/24/1999EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/24/1999EP0903339A2 Biphenylsulfonylcyanamides, process for their preparation and their use as medicaments
03/24/1999EP0903152A2 Bifunctional water-soluble polymer derivative and complex containing it
03/24/1999EP0902839A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells
03/24/1999EP0902783A1 Hydrolysis-promoting taxane hydrophobic derivatives
03/24/1999EP0902782A1 Urea derivatives as inhibitors of impdh enzyme
03/24/1999EP0902779A2 Phosphate mimics
03/24/1999EP0902687A1 Polymeric delivery of radionuclides and radiopharmaceuticals
03/24/1999EP0902682A2 Cationic virosomes as transfer system for genetic material
03/24/1999EP0902681A1 Inhibition of selectin binding
03/24/1999EP0810878B1 Rna photocleavage using texaphyrins
03/24/1999EP0480950B1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
03/24/1999CN1212016A Recombinant ribonuclease proteins
03/24/1999CN1211987A Camptothecin derivatives and use thereof as antimutor agents
03/24/1999CN1211985A Fused imidazole derivatives as multidrug resistance modulators
03/24/1999CN1211926A Pharmaceutical composition for immunomodulation based on peptides and adjuvants
03/24/1999CN1211921A Benzothiophenes, formulations containing same and process of preparing same
03/24/1999CN1211432A Anticancer oral liquid and its preparation method
03/23/1999US5886179 Nucleotide analogs
03/23/1999US5886152 Humanized antibody produced by transplantation of complementarity-determining region of a mouse monoclonal antibody b-b10 specific to a human interleukin-2 receptor into a human antody; genetic engineering
03/23/1999US5886150 Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof
03/23/1999US5886147 Compounds useful for the synthesis of dolastatin analogs
03/23/1999US5886145 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
03/23/1999US5886053 Use of carotenoids for producing drugs for the treatment of dermatoses
03/23/1999US5886048 PHMB for the treatment of tumor disease
03/23/1999US5886043 Antiarthritic agents, antitumor agents, antiinflammatory agents
03/23/1999US5886036 Treating hiv infections
03/23/1999US5886033 Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders
03/23/1999US5886025 Methoxy and ethoxy substituted 3-aroyl-2-arylbenzo(b)thiophenes and benzo(b)thiophene analogues
03/23/1999US5886024 Thiophene-containing butonic acid derivatives as matrix metalloprotease inhibitors
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999US5885996 An enzyme inhibitors of thymidylate synthase works as bactericides, fungicides inhibiting yeasts, fungi
03/23/1999US5885972 L-pyranosyl nucleosides
03/23/1999US5885805 gbpA
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885795 Methods of expressing angiostatic protein
03/23/1999US5885592 Methods and pharmaceutical compositions for oral delivery of molecular iodine
03/23/1999US5885575 Diagnosis and therapy of tumour metastases
03/23/1999US5885547 Particulate material
03/23/1999CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them
03/23/1999CA1340456C Chimeric rodent/human immunoglobulins specific for tumor-associated antigens
03/22/1999CA2247749A1 Biphenylsulfonylcyanamides, process for their preparation, and their use as medicament
03/18/1999WO1999013329A1 Methods of identifying molecules that home to angiogenic vasculature in tumors
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013078A1 Cysteine rich receptors-train
03/18/1999WO1999013073A2 Viral vector system capable of expressing an apoptosis-associated gene
03/18/1999WO1999013071A1 Human papilloma virus inhibition by anti-sense oligonucleotides
03/18/1999WO1999013053A1 Genetically modified tumor-targeted bacteria with reduced virulence
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012965A2 April- a novel protein with growth effects
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012963A2 Cysteine rich receptors: trail
03/18/1999WO1999012962A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
03/18/1999WO1999012961A1 Estrogen receptor
03/18/1999WO1999012951A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
03/18/1999WO1999012945A2 Hydrophobic glycosylamine derivatives, compositions, and methods for use
03/18/1999WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
03/18/1999WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999WO1999012917A1 Ureido and thioureido derivatives of 4-amino-2(5h)-furanones and 4-amino-2(5h)-thiophenones as antitumor agents
03/18/1999WO1999012916A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999WO1999012905A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999WO1999012901A1 Substituted 2-pyrrolidinone activators of pkc
03/18/1999WO1999012894A1 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
03/18/1999WO1999012640A1 Coated particles, methods of making and using
03/18/1999WO1999012574A1 Improvements in or relating to expression of immunogenic substances
03/18/1999WO1999012573A1 Improvements in or relating to regulation of t cell activation
03/18/1999WO1999012570A2 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012543A1 Dithiolopyrrolones and their corresponding monoxides and dioxides as antineoplastic agents
03/18/1999WO1999012531A2 Hormonal contraceptive
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1998058635A3 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
03/18/1999WO1998057987A3 Irs-p53h, human insulin receptor tyrosine kinase substrate
03/18/1999WO1998056909A3 Secreted proteins and polynucleotides encoding them
03/18/1999WO1998055510A3 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
03/18/1999WO1998008481A3 Process and apparatus for the production of bi-212 and a use thereof
03/18/1999DE19740571C1 Antigen-specific stimulation of T cells
03/18/1999DE19739916A1 Mittel zur hormonalen Kontrazeption Means for hormonal contraception
03/18/1999CA2569685A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999CA2305575A1 Hydrophobic glycosylamine derivatives, compositions, and methods for use
03/18/1999CA2303618A1 Improvements in or relating to expression of immunogenic substances
03/18/1999CA2303617A1 Improvements in or relating to regulation of t cell activation
03/18/1999CA2303615A1 April- a novel protein with growth effects
03/18/1999CA2303462A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
03/18/1999CA2303424A1 Kay - a novel immune system protein
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2303248A1 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2303146A1 Substituted 2-pyrrolidinone activators of pkc
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302687A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
03/18/1999CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
03/18/1999CA2302284A1 Ureido and thioureido derivatives of 4-amino-2(5h)-furanones and 4-amino-2(5h)-thiophenones as antitumor agents
1 ... 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 ... 2211